Skip to main content
Caplight Logo









Everly Bio

Everly Bio

Private
JerusalemAI, Data & Cloud Infrastructurehttps://everly.bio/

Last Round

Accelerator

Jan 1, 2023

Company Overview

Everly Bio is a biotechnology company that operates a computational biology process using an AI-driven, non-invasive approach for decision-support in fertility care.

Sector

AI, Data & Cloud Infrastructure

Verticals

Workflow Automation, Vertical SaaS, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticssperm analysis testfertility techpredictive diagnosticsmale infertility testAI diagnosticsreproductive health techIVF outcomes predictionclinical decision supportcomputational biologynon-invasive testIVF techbiomarker panelsextracellular vesicle

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Everly Bio Comparables

Compare Everly Bio with similar companies based on industry and business-model similarity.

Everly Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carly AI
80%
Lindy
78%
alfred_
70%

Everly Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 1, 2023

Key People

Founding team and executive leadership

Michal Gilon Ohev-Zion

Co-Founder, CTO & COO, CEO and Co-Founder at Everly Bio

Founding Team

Everly Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2023

    Led by VLX Ventures with participation from Yissum.

Everly Bio Filings

Explore SEC and related filing metadata, where available.

Everly Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Everly Bio's valuation, stock price, and market status.

Is Everly Bio a public or private company?

Everly Bio is a private company.

What is the current stock price of Everly Bio?

Everly Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Everly Bio worth (valuation)?

Valuation information for Everly Bio is not publicly available.

Can I buy Everly Bio stock?

Everly Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Everly Bio's last funding round?

Funding round information for Everly Bio is not publicly available.

Who are the main investors in Everly Bio?

Investor information for Everly Bio is not publicly disclosed.

Will Everly Bio IPO soon?

No public IPO plans have been announced for Everly Bio.

How can I track Everly Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Everly Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJerusalem
Employee Range4
Year Founded2022
Last FundingJan 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?